- increased circulating calcium level / IMPC
- increased leukocyte cell number / IMPC
- decreased body length / IMPC
- abnormal locomotor behavior / IMPC
- hyperactivity / IMPC
- decreased locomotor activity / IMPC
- decreased exploration in new environment / IMPC
- increased startle reflex / IMPC
- male infertility / IMPC
- increased mean corpuscular volume / IMPC
- increased hematocrit / IMPC
- decreased vertical activity / IMPC
- increased thigmotaxis / IMPC
- increased circulating alanine transaminase level / IMPC
- increased circulating alkaline phosphatase level / IMPC
- decreased circulating chloride level / IMPC
- abnormal behavior / IMPC
- impaired glucose tolerance / IMPC
- increased circulating aspartate transaminase level / IMPC
- increased circulating glucose level / IMPC
- decreased mean corpuscular hemoglobin concentration / IMPC
- decreased grip strength / IMPC
- aorta stenosis / IMPC
- decreased food intake / IMPC
- increased fasting circulating glucose level / IMPC
C57BL/6N-Cpetm1b(EUCOMM)Hmgu/Ieg
Status | Available to order |
EMMA ID | EM:08086 |
International strain name | C57BL/6N-Cpetm1b(EUCOMM)Hmgu/Ieg |
Alternative name | HEPD0594_7_A02 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Cpetm1b(EUCOMM)Hmgu |
Gene/Transgene symbol | Cpe |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH) |
Provider affiliation | Institute of Experimental Genetics, Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH) |
Genetic information | This mouse line originates from EUCOMM ES clone HEPD0594_7_A02. For further details on the construction of this clone see the page at the IMPC portal. The critical exon(s) were flanked by loxP sites, and subsequent cre expression excised this critical sequence resulting in a knockout reporter allele (Gt(ROSA)26Sor |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH), Oberschleißheim, Germany |
Animals used for archiving | heterozygous C57BL/6NTacUSA |
Disease and phenotype information
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- decreased locomotor activity / IMPC
- decreased vertical activity / IMPC
- decreased grip strength / IMPC
- impaired glucose tolerance / IMPC
- decreased mean corpuscular hemoglobin concentration / IMPC
- aorta stenosis / IMPC
- decreased exploration in new environment / IMPC
- abnormal locomotor behavior / IMPC
- increased circulating alkaline phosphatase level / IMPC
- increased startle reflex / IMPC
- increased leukocyte cell number / IMPC
- increased mean corpuscular volume / IMPC
- increased circulating glucose level / IMPC
- decreased food intake / IMPC
- increased circulating alanine transaminase level / IMPC
- decreased body length / IMPC
- increased circulating aspartate transaminase level / IMPC
- increased fasting circulating glucose level / IMPC
- abnormal behavior / IMPC
- hyperactivity / IMPC
- increased thigmotaxis / IMPC
- increased circulating calcium level / IMPC
- increased hematocrit / IMPC
- decreased circulating chloride level / IMPC
- male infertility / IMPC
MGI phenotypes (gene matching)
- increased circulating LDL cholesterol level / MGI
- hypoglycemia / MGI
- decreased digestive secretion / MGI
- tremors / MGI
- increased body length / MGI
- obese / MGI
- hypoactivity / MGI
- abnormal gait / MGI
- polyphagia / MGI
- abnormal motor coordination/balance / MGI
- abnormal placing response / MGI
- increased circulating triglyceride level / MGI
- increased circulating HDL cholesterol level / MGI
- hyperglycemia / MGI
- abnormal hypothalamus secretion / MGI
- reduced fertility / MGI
- infertility / MGI
- abnormal motor capabilities/coordination/movement / MGI
- abnormal glucose homeostasis / MGI
- increased circulating insulin level / MGI
- abnormal muscle physiology / MGI
- decreased circulating adrenocorticotropin level / MGI
- decreased vertical activity / MGI
- abnormal hormone level / MGI
- increased pituitary hormone level / MGI
- abnormal physical strength / MGI
- decreased circulating gastrin level / MGI
- increased circulating pituitary hormone level / MGI
- increased circulating growth hormone level / MGI
- increased growth hormone level / MGI
- increased circulating VLDL cholesterol level / MGI
- increased circulating cholesterol level / MGI
- lethargy / MGI
- abnormal pancreatic beta cell morphology / MGI
- impaired glucose tolerance / MGI
- insulin resistance / MGI
- abnormal energy expenditure / MGI
- abnormal percent body fat/body weight / MGI
- increased circulating triiodothyronine level / MGI
- pancreatic islet hyperplasia / MGI
- hyporesponsive to tactile stimuli / MGI
- increased circulating glucose level / MGI
- increased circulating leptin level / MGI
- increased pancreatic islet number / MGI
- degranulated pancreatic beta cells / MGI
- increased total body fat amount / MGI
- decreased grip strength / MGI
- increased respiratory quotient / MGI
- impaired adaptive thermogenesis / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).